RxDoctor Payments Data

Jacqueline Johnson, DO

Family Medicine · Myrtle Creek, ORNPI 1083814099

Payments from drug & device makers

$517in general payments, 2019–2025

Across 26 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$185
  • AstraZeneca$109
  • Novo Nordisk$67
  • Exact Sciences$34
  • Blueprint Medicines Corporation$31
  • Pfizer$27
  • plus $64 from 3 others

What the payments were for

  • Food & beverage$48594%
  • Education$326%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$517 in reported general payments places this provider in the 80th percentile of 1,221 family medicine providers in Oregon.

See all family medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$3,098
Medicare patients
55
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban81$66,254
TrulicityDulaglutide38$47,775
TriumeqAbacavir/Dolutegravir/Lamivudi12$41,984
JardianceEmpagliflozin46$40,806
OzempicSemaglutide22$22,125
Semglee (Yfgn) PenInsulin Glargine-Yfgn43$20,014
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,203
FarxigaDapagliflozin Propanediol21$13,906
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$11,656
XareltoRivaroxaban13$9,956
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$8,610
MyrbetriqMirabegron13$7,450
Spiriva RespimatTiotropium Bromide11$6,702
TradjentaLinagliptin11$5,477
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$4,369

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$66,25481 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$26$52,98668 claims
AstraZenecaFarxiga, Breztri Aerosphere$109$22,51632 claims
Novo NordiskOzempic$67$22,12522 claims
GSKTrelegy Ellipta$185$18,20322 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,221 family medicine providers in Oregon.

Other family medicine in Myrtle Creek

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →